Levonorgestrel-releasing Intrauterine System and Tubal Ligation
Levonorgestrel-releasing Intrauterine System and Tubal Ligation
Today tubal sterilization is a simple, safe, and cost-effective method of achieving long-term
 contraception. Sterilization is an ideal method of permanent contraception in developing
 countries where access to health care providers is limited. The percentage of women who use
 sterilization as a method of contraception rises from about 5% between 20 and 24 years of age
 to almost 50% for those between 40 and 44 years of age. The most widely touted and most
 significant health benefit of tubal sterilization appears to be a reduced risk of ovarian
 cancer.

 Post-tubal ligation syndrome includes pain during intercourse, aching lower back,
 premenstrual tension syndrome, uterine hemorrhage, and absence of menstruation. The syndrome
 is caused by blood circulation problems in and around the Fallopian tubes and ovaries,
 pressure on nerves, and intrapelvic adhesion. Since the symptoms of this syndrome are mild,
 simple symptomatic treatment is sufficient in most cases. In some cases, however,
 hysterectomy may be necessary.
Inclusion Criteria:

 -  Women aged from 30-40 year

 -  Woman subjected to tubal ligation

 -  Women 12 month postpartum

 -  Non lactating women

 -  Nomedical disorders

 Exclusion Criteria:

 -  contraindication for Levonorgestrel-releasing Intrauterine System

 -  Women with any uterine or ovarian pathology

 -  women refuse to participate